Inside of a mouse model, offering genetic validation of CRK12:CYC9 to be a novel drug goal for trypanosomiasis. Further more, practical characterisation of CRK12 and CYC9 utilizing RNA interference reveals roles for these proteins in endocytosis and cytokinesis, respectively. As well as in vivo antileishmanial efficacy of a mixture therapy https://brettp885zku9.onzeblog.com/profile